|
Gallium-68 labelled (68Ga-) FAP-2286 Clinical Trials
2 actively recruiting trials across 1 location
No change since May 2026
Also known as: 68Ga-FAP-2286
Pipeline
Phase 1: 2
Top Sponsors
- Yi Tian1
- Thomas Hope1
Indications
- Metastatic Cancer2
- Cancer2
- Solid Tumors, Adult1
- Tumor1
Other1 trial
San Francisco, California1 trial
Imaging of Solid Tumors Using FAP-2286
University of California, San Francisco
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.